Literature DB >> 19330523

Walker 256 cancer cells secrete tissue inhibitor of metalloproteinase-free metalloproteinase-9.

Maria Pavlaki1, Eleftheria Giannopoulou, Anna Niarakis, Panagiota Ravazoula, Alexios J Aletras.   

Abstract

Walker 256 (W256) cancer cells, developed as ascites in rats, in response to endogenous unidentified stimuli, secrete a gelatinase of apparent molecular mass of 94 kDa, immunologically homologous to the zymogen of matrix metalloproteinase-9 (proMMP-9). After treatment with the activating agent 4-aminophenylmercuric acetate (APMA), affinity-purified W256 gelatinase is converted to a final processed form of 66 kDa in a similar fashion to TIMP-free human proMMP-9. It is demonstrated that although being capable of binding TIMP-1, W256 proMMP-9 is secreted from W256 cells in TIMP-free forms (monomers or oligomers). Moreover, using biochemical and immunological methods, it is established that the W256 cells do not express or secrete TIMP-1 protein, although RT-PCR analysis indicated low-level TIMP-1 mRNA expression. W256 cancer cells displayed high metastatic ability in rats that may be attributed in part to secretion of TIMP-free proMMP-9.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330523     DOI: 10.1007/s11010-009-0089-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  80 in total

1.  Natural human monocyte gelatinase and its inhibitor.

Authors:  G Opdenakker; S Masure; P Proost; A Billiau; J van Damme
Journal:  FEBS Lett       Date:  1991-06-17       Impact factor: 4.124

2.  Human neutrophil collagenase.

Authors:  H Tschesche
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics.

Authors:  G Mautino; N Oliver; P Chanez; J Bousquet; F Capony
Journal:  Am J Respir Cell Mol Biol       Date:  1997-11       Impact factor: 6.914

Review 6.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

7.  Evidence for the tissue inhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes.

Authors:  S Triebel; J Bläser; T Gote; G Pelz; E Schüren; M Schmitt; H Tschesche
Journal:  Eur J Biochem       Date:  1995-08-01

8.  Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats.

Authors:  P J Kostenuik; F W Orr; K Suyama; G Singh
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

9.  Proteolytic and non-proteolytic activation of human neutrophil progelatinase B.

Authors:  Q X Sang; H Birkedal-Hansen; H E Van Wart
Journal:  Biochim Biophys Acta       Date:  1995-09-06

10.  Inhibition of angiogenesis by anthracyclines and titanocene dichloride.

Authors:  M E Maragoudakis; P Peristeris; E Missirlis; A Aletras; P Andriopoulou; G Haralabopoulos
Journal:  Ann N Y Acad Sci       Date:  1994-09-06       Impact factor: 5.691

View more
  1 in total

1.  The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain.

Authors:  Priyank A Shenoy; Andy Kuo; Nemat Khan; Louise Gorham; Janet R Nicholson; Laura Corradini; Irina Vetter; Maree T Smith
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.